Financhill
Back

Structure Therapeutics Vs. Novo Nordisk AS Industry Stock Comparison

Sell
30

GPCR
Structure Therapeutics

Last Price:
37.44
Seasonality Move:
-29.59%
Sell
40

NVO
Novo Nordisk AS

Last Price:
113.94
Seasonality Move:
5.67%
Sell
30
Structure Therapeutics (GPCR) is a Sell

Is Structure Therapeutics a Buy, Sell or Hold?

  • The current Structure Therapeutics [GPCR] share price is $38.07. The Score for GPCR is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
  • GPCR is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
40
Novo Nordisk AS (NVO) is a Sell

Is Novo Nordisk AS a Buy, Sell or Hold?

  • The current Novo Nordisk AS [NVO] share price is $115.74. The Score for NVO is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
  • NVO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

GPCR Stock Price Chart

What is Structure Therapeutics's stock price today?

  • The Structure Therapeutics share price today is $38.07
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and GPCR is experiencing slight selling pressure.

NVO Stock Price Chart

What is Novo Nordisk AS's stock price today?

  • The Novo Nordisk AS share price today is $115.74
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NVO is experiencing slight buying pressure.

GPCR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.45 Sell
Relative Strength Index (14 RSI): 44.56 Sell
Chaikin Money Flow: -194701 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (38.28 - 42.62) Sell
Bollinger Bands (100): (35.56 - 45.66) Sell

NVO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -3.05 Sell
Relative Strength Index (14 RSI): 34.51 Sell
Chaikin Money Flow: 205594 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (115.31 - 125.67) Sell
Bollinger Bands (100): (123.66 - 141.3) Sell

GPCR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 38.24 Sell
20-day SMA: 40.3 Sell
50-day SMA: 39.44 Sell
200-day SMA: 40.54 Sell
8-day EMA: 38.81 Sell
20-day EMA: 39.47 Sell
50-day EMA: 39.57 Sell
200-day EMA: 39.79 Sell

NVO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 117.91 Sell
20-day SMA: 118.43 Sell
50-day SMA: 127.73 Sell
200-day SMA: 128.02 Sell
8-day EMA: 117.31 Sell
20-day EMA: 119.68 Sell
50-day EMA: 124.93 Sell
200-day EMA: 123.69 Sell

Structure Therapeutics Earnings Growth & GPCR Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.11 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.13 per share, and an increase next year of $0.07 per share.

Novo Nordisk AS Earnings Growth & NVO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.60 per share, and an increase next year of $0.79 per share.

Structure Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Novo Nordisk AS Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):